Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.

Cell reports methods·2026

Same author

Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions.

Cells & development·2026

Same author

Paradoxical hypercalcemia in tuberculosis with concurrent vitamin D deficiency: mechanisms, clinical implications, and management strategies.

Annals of medicine and surgery (2012)·2026

Same author

Non-ST-Segment Elevation Myocardial Infarction in a Patient With Dextrocardia.

JACC. Case reports·2026

Same author

Chemoselective C-Terminal Activation Platform for Direct Conversion of Native Linear Peptides into Thiazoline/Thiazole Macrocycles.

Organic letters·2026

Same author

Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for Glycemic Control in Pediatric Patients With Type 1 Diabetes Mellitus: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

AACE endocrinology and diabetes·2026

Search research articles

Related Experiment Video

Updated: Jan 10, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

Ischemic Preconditioning in Atrial Fibrillation.

Mohamed Ahmed Mohamed¹, Sankirtana Gorva², Ahmad Hammoud³

¹David Tvildiani Medical University, Tbilisi, Georgia.

Discoveries (Craiova, Romania)

|November 24, 2025

Summary

Ischemic preconditioning (IPC) shows promise for treating atrial fibrillation (AF) by reducing arrhythmia complications. Further research is needed to integrate this cardioprotective strategy into routine clinical practice.

Keywords:

Atrial fibrillation ablation.ischemic preconditioning myocardial ischemia

More Related Videos

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Related Experiment Videos

Last Updated: Jan 10, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Area of Science:

Cardiology
Electrophysiology
Translational Medicine

Background:

Atrial fibrillation (AF) is a prevalent arrhythmia globally, with current treatments focusing on complication reduction rather than definitive cures.
Ischemic preconditioning (IPC), involving brief ischemia/reperfusion cycles, is an emerging cardioprotective strategy.
Existing AF treatments like anticoagulants, rate control, and catheter ablation primarily manage complications.

Purpose of the Study:

To comprehensively review and discuss recent clinical trials on ischemic preconditioning (IPC) for atrial fibrillation (AF) treatment.
To evaluate IPC as a potential therapeutic alternative for managing AF.
To explore the impact of IPC on rhythm control, pharmacologic responsiveness, and cardioversion outcomes in AF patients.

Main Methods:

Systematic review and analysis of recent clinical trials investigating IPC in surgical and interventional settings for AF.
Examination of evidence regarding the protective mechanisms of IPC in atrial tissue.
Assessment of factors contributing to heterogeneity in trial outcomes, including patient selection and preconditioning protocols.

Main Results:

Clinical trials demonstrate encouraging evidence of IPC's ability to reduce atrial arrhythmia.
IPC has shown potential benefits in improving rhythm control, pharmacologic responsiveness, and cardioversion success rates in AF.
Heterogeneity in results is noted, attributed to variations in patient selection, anesthetic regimens, and IPC protocols.

Conclusions:

Ischemic preconditioning (IPC) holds significant therapeutic potential as a novel strategy for treating atrial fibrillation (AF).
IPC may offer benefits beyond current treatments by addressing underlying mechanisms and improving outcomes.
Further research is essential to optimize IPC protocols and translate findings into routine clinical practice, especially for high-risk AF populations.